𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic potential of interleukin-6 antagonism in bipolar disorder

✍ Scribed by E. Brietzke; M. Scheinberg; B. Lafer

Book ID
116745669
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
218 KB
Volume
76
Category
Article
ISSN
0306-9877

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

GSK-3 is a viable potential target for t
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
✍ Michael K. Rowe; Charlotte Wiest; De-Maw Chuang πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 248 KB

Bipolar disorder is a serious psychiatric condition that has been treated for over 50 years with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor, suggesting that manipulating GSK-3 may have therapeutic value in treating bipolar disorder. GSK-3 is regulated by a wi